$CDNA Income Statement | Understand Stock

$CDNA

$70.53 +$1.43 (2.07%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Testing services revenue
Product revenue
Patient and digital solutions revenue
Total revenue
Operating expenses:
Cost of testing services, product, patient and digital solutions
Testing services revenue
Product revenue
Patient and digital solutions revenue
Research and development
Sales and marketing
General and administrative
Restructuring costs
Litigation settlement expense
Total operating expenses
(Loss) income from operations
Other income:
Interest income, net
CARES Act Provider Relief Fund
Change in estimated fair value of common stock warrant liability
Other income, net
Total other income

(Loss) income before income taxes
Income tax expense
Net loss
Net (loss) income
Net (loss) income per share (Note 3):
Basic (in dollars per share)
Diluted (in dollars per share)
Weighted-average shares used to compute net (loss) income per share:
Basic (in shares)
Diluted (in shares)

Comments